-+ 0.00%
-+ 0.00%
-+ 0.00%

XENON PHARMACEUTICALS INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $60 FROM $70

Reuters·10/08/2026 11:09:25

Please log in to view news